Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $311.79M | $248.04M | +25.70% |
Operating Income | $-586.77M | $-99M | -492.70% |
Net Income | $-616.96M | $-110.21M | -459.80% |
EPS (Basic) | $-9.02 | $-2.11 | -327.49% |
EPS (Diluted) | $-9.02 | $-2.11 | -327.49% |
R&D Expense | $92.36M | $43.03M | +114.63% |
SG&A Expense | $542.64M | $140.24M | +286.94% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $864.61M | — | — |
Current Assets | $671.37M | — | — |
Total Liabilities | $766.36M | — | — |
Current Liabilities | $181.56M | — | — |
Stockholders' Equity | $98.25M | $-1.26B | +107.80% |
Cash & Equivalents | $478.81M | $202.27M | +136.72% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-198.46M | $-121.09M | -63.90% |
Investing Cash Flow | $8.98M | $-18.77M | +147.84% |
Financing Cash Flow | $502.63M | $39.18M | +1182.88% |
Dividends Paid | $5.63M | $5.63M | 0.00% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -188.2% | -39.9% | -148.28% |
Net Margin | -197.9% | — | — |
ROE | -627.9% | — | — |
ROA | -71.4% | — | — |
Current Ratio | $3.698 | — | — |
Debt to Equity | $7.8 | — | — |
Other companies in Life Sciences Tools & Services